RTKN and hepatocellular carcinoma: The investigation of the overexpression and silencing of Rhotekin in HCC cell lines, HepG2 and Hep3B, revealed that Rhotekin may function as an oncogene by promoting the proliferation and inhibiting apoptosis of these cells [23].